{
    "2019-01-25": [
        [
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：预计2018年同比扭亏为盈",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2018年",
                        "扭亏为盈"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物(300142.SZ)预计2018年度业绩扭亏为盈 实现净利润10.44亿—10.49亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "300142.SZ",
                        "2018年度",
                        "扭亏为盈",
                        "净利润",
                        "10.44亿—10.49亿元"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：2018年预盈10.4亿元",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "2018年",
                        "预盈",
                        "10.4亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}